Annex 1 In Practice: Turning CCS Into Cleanroom Design

Aseptic processing demands that sterility risks be designed out of facilities rather than tested into finished products. Under the revised EU GMP Annex 1 guidelines, a Contamination Control Strategy (CCS) must serve as the primary driver of cleanroom design from concept through operation, rather than acting as a late-stage summary document. Critical exposure points—such as open product manipulations, manual operator interventions, and material or personnel transfers—require targeted engineering controls. Evaluating process risks through six key design lenses, including pressure cascades, barrier selection, and airflow visualization, prevents costly facility retrofits and regulatory observations. Aligning room classification directly with actual process risk protects product quality and accelerates project timelines. Discover how embedding risk management into front-end conceptual planning ensures compliance and safeguards continuous manufacturing operations.